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Abstract
The demand for accelerated forms of evidence synthesis is on the rise, largely in response to requests by health care
decision makers for expeditious assessment and up-to-date information about health care technologies and health
services and programs. As a field, rapid review evidence synthesis is marked by a tension between the strategic priority
to inform health care decision-making and the scientific imperative to produce robust, high-quality research that
soundly supports health policy and practice.
In early 2015, the Canadian Agency for Drugs and Technologies in Health convened a forum in partnership with the
British Columbia Ministry of Health, the British Columbia Centre for Clinical Epidemiology and Evaluation, the Ottawa
Hospital Research Institute, and the University of Pennsylvania. More than 150 evidence synthesis producers and end
users attended the Rapid Review Summit: Then, Now and in the Future. The Summit program focused on the evolving
role and practices of rapid reviews to support informed health care policy and clinical decision-making, including the
uptake and use of health technology assessment.
Our discussion paper highlights the important discussions that occurred during the Rapid Review Summit. It focuses
on the initial development of a research agenda that resulted from the Summit presentations and discussions. The
research topics centered on three key areas of interest: (1) how to conduct a rapid review; (2) investigating the validity
and utility of rapid reviews; and (3) how to improve access to rapid reviews.
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Background
The demand for accelerated forms of evidence synthe-
sis—referred to in this paper as rapid reviews—is on the
rise, largely in response to requests for prompt assessment
and up-to-date information by health care decision
makers about health care technologies, and health services
and programs [1–4]. Heightened interest in rapid re-
views, coupled by the dearth of published evidence, has
been underscored by a recent Systematic Reviews jour-
nal series on the subject, accessed more than 9000 times
since January 2015 [4]. Another manuscript on rapid re-
view approaches continues to be one of the most highly
accessed articles in the journal, retrieved more than
23,000 times since its publication in 2012, 800 times
alone in January 2015 [5].
Three 2015 publications presented the processes and
methods involved with the production of rapid reviews
[2–4]. One paper explored the methods and context for
the production of 36 rapid reviews from 20 organiza-
tions and conducted interviews with rapid review pro-
ducers, and another study performed a descriptive
analysis of processes and methods for 29 international
rapid review programs [2, 3]. Both studies indicated that
there is no standard definition of rapid reviews or
methods to produce them, possibly attributed to the
timeframe and type of evidence synthesis employed to
complete a report [2, 3]. The third study proposed gen-
eral principles to produce rapid reviews that were
aligned with the methods used for systematic reviews to
improve their transparency [4]. Rapid review evidence
synthesis is marked by a tension between the strategic
priority of informing health care decision-making, while
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addressing the scientific imperative for the production of
robust, high-quality research that soundly supports health
policy and practice [5, 6]. As the demand for rapid reviews
continues to grow, there is an opportunity, considerable
interest, and urgency for harnessing producer and end-user
insights to guide the development of this field.
In early 2015, the Canadian Agency for Drugs and Tech-
nologies in Health (CADTH) convened a forum in partner-
ship with the British Columbia Ministry of Health, the
British Columbia Centre for Clinical Epidemiology and
Evaluation, the Ottawa Hospital Research Institute, and the
University of Pennsylvania. The Rapid Review Summit:
Then, Now and in the Future focused on the evolving role
and practices of rapid reviews to support informed health
care policy and clinical decision-making, including the up-
take and use of health technology assessment (HTA). More
than 150 participants attended the Summit. They were pri-
marily rapid review producers (who are among the cham-
pions of creative efforts in this area) and end users of rapid
reviews (decision makers at the forefront of clinical and
policy decisions). Participants came from a wide range of
health research and practice settings across Canada and
internationally including government, research institutions,
academia, not-for-profit organizations, and industry.
A planning committee of experts in the field devel-
oped the scientific program for the Summit and articu-
lated four objectives. They were as follows: (i) to share
information among health care decision makers and
providers, rapid review producers, and representatives
from organizations interested in rapid reviews; (ii) to
facilitate discussions concerning the production of
rapid review reports and their use to support informed
decision-making; (iii) to initiate the development of a
priority research agenda to further advance the science
of rapid reviews; and (iv) to contribute to the ongoing
development of a community of practice for rapid re-
views to facilitate continued information sharing and
collaborations among rapid review producers and
health decision makers.
This discussion paper highlights the important discus-
sions that occurred during the Rapid Review Summit. In
particular, this paper focuses on the initial development of a
research agenda from the Summit presentations and dis-
cussions. The purpose of this research agenda is to identify
research topics to advance the science in rapid review defi-
nitions and methods and to enhance their application to
support informed health care decision-making for both the
users and producers of rapid reviews.
Methods
The scientific program was comprised of six oral ses-
sions presented by 14 North American and international
speakers. They included Jesmin Antony, Vivian Coates,
Chantelle Garritty, Jeanne-Marie Guise, Chris Kamel, Janet
Joy, Craig Mitton, David Moher, Michelle Mujoomdar,
Susan L. Norris, Julie Polisena, Kevin Samra, Sharon E.
Straus, Lesley Stewart, Andrea C. Tricco, and Craig A.
Umscheid [7]. Each session lasted between 60 and
90 min. Four presenters represented decision makers,
who discussed how they incorporate rapid reviews in
their decision-making process and the expectations,
appropriateness, and risks associated with the use of
rapid reviews. Some of the other sessions presented by
rapid review producers compared rapid reviews with
systematic reviews, the risks and opportunities with
publishing rapid reviews, and the impact of rapid re-
views in HTA.
The Summit concluded with an exercise, where ideas
for an ongoing research agenda were solicited from par-
ticipants. The presentations and discussions were audio-
recorded, and each group submitted their research ideas
in writing. The detailed program is available on the
CADTH website [7].
In the exercise, 11 randomly formed groups of four to
six participants worked together for 40 min to propose
research project ideas. They were asked to start the dis-
cussion by sharing ideas for “a priority research agenda
for rapid reviews” based on their experience, expertise,
and what they heard during the Summit; to identify
similarities and overlaps; and then to submit the group’s
top three ideas for review by the Summit planning team.
Some groups submitted more than three ideas resulting
in a total of 50 ideas when collated.
Following the Summit, all ideas submitted were listed
verbatim and reviewed to identify unique themes in an
inductive manner by one individual (JW) and verified by
another reviewer (JP). A list of themes was reviewed by
comparing and contrasting the ideas in each theme and
to decide whether they should be expanded or merged.
Two individuals (JW and JP) compared their results and
achieved consensus through discussion. Unique themes
that emerged from the research ideas submitted by the
Summit participants helped to inform the development
of a rapid review research agenda.
Results
The Summit focused on generating dialogue in response
to questions that are familiar to those most active in the
evidence synthesis field, including:
 When is it appropriate to undertake a rapid review?
 What are the role of, scope of, and approaches to
conducting rapid reviews?
 What potential risks of bias are associated with
rapid reviews given the existing methodological
approaches?
 Are rapid reviews a natural extension of systematic
reviews? Should they be?
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 Are they effectively influencing end-user decision-
making?
 Can rapid reviews be considered credible given the
lack of consistency in terminology and practice?
Seven topic areas for a research agenda emerged from
the final Summit exercise, including theory and taxonomy,
methods and application, comparing and contrasting with
systematic reviews, evaluation of use, database develop-
ment, influence on practice, and suggestions for tool and
guideline development (Table 1).
Taxonomy and definitions
The imperative to establish rapid review taxonomy and
definitions reinforced the importance of moving forward
with standard definitions, shared terminology, and con-
cepts as a foundation for the field. Participants noted the
difficulty of engaging in scientific discourse in the ab-
sence of a consistent lexicon of terms.
Methods, processes, and application
The majority of ideas for future research focused on the
area of methods and their application to guide rigorous
scientific practice at every stage of rapid review product
development. Suggestions included exploring methods
used for problem delineation, the development of ques-
tions that are suitable in focus and scope for rapid re-
views, or as one group stated, developing a “process
map” for what would trigger the need for a full system-
atic review versus a rapid review. Research that informs
best practices for accelerated evidence synthesis along
with methodological guidelines was suggested. The need
to describe trade-offs between time, resources, and com-
prehensiveness was identified to ensure that users are
aware of product limitations and “the need to interpret
results and conclusions with caution.”
Comparing and contrasting with systematic reviews
Systematic reviews were the main reference point in discus-
sions about the development of rapid review methods and
practice; thus, a number of research ideas focused on the
potential benefit of comparative work. One idea suggested
research on the unique dynamics of the producer and end-
user relationship in the development of rapid reviews. Spe-
cific reference was made to exploring the dynamics through
“a comparative analysis that focuses on the perspectives of
end users.” Other suggested areas of comparative study in-
cluded seeking approaches to mitigate risks associated with
bias and evaluating comparative levels of accuracy and up-
take in health policy and practice decisions.
Evaluation of use
Participants identified the need for rapid review evalua-
tions to describe users, to understand how and when
rapid reviews are being used, and to delineate existing
practices and their outcomes. The congruence of con-
clusions between systematic reviews and rapid reviews,
undertaken in the same timeframe on the same topics if
additional resources are allocated to conducting the sys-
tematic review, was of interest to participants. With ref-
erence to product impact, an evaluation of how rapid
reviews influence decision-making in health policy and
practice was suggested. Interest was also expressed in
reviewing policy decisions made using rapid reviews
once systematic reviews have been published on the
same topic. Evaluation is also needed to guide develop-
ment of metrics to assist with measuring and quantifying
the various dimensions of rapid reviews, including their
quality and validity of content.
Development of a database
A number of ideas focused on the importance of develop-
ing a free, international database or repository of rapid re-
view products, as well as related tools and other resources.
Development of a rapid review database reinforces the
urgency for standard definitions, shared terminology,
and concepts in order to ensure consistency in their
categorization. Otherwise, there would be risks of
jeopardizing the credibility of rapid review science.
Existing practices for the registration of systematic re-
views might be useful in guiding further research into
logistics of database development, as well as architec-
ture, management, opportunities, and constraints.
Tools and guidelines
There was a high level of interest in the generation and
dissemination of tools and guidelines to enhance meth-
odological consistency and stimulate rapid review devel-
opment processes. A number of agencies shared
information about tools and guidelines already in use to
support and systematize their rapid review develop-
ment. Linked with tools and resources were suggestions
for flowcharts to guide process, and product templates
and guidelines to support consistency and uniformity of
methodological practice. A tool that assists with “grad-
ing” rapid reviews and their level of uncertainty might
be useful to decision makers. While it was noted that
the lack of shared terminology and methods forms a
barrier to common tools and guidelines, their develop-
ment and dissemination through publication may sup-
port methodological consistency with time.
Influencing practice
The area of influencing practice emerged as a minor yet
cross-cutting theme. Reference was made to engendering
collaboration, momentum, and communication of best
practices to collectively advance the field. The develop-
ment of a community of practice that involves end users
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Table 1 A research agenda for rapid reviews
Themes Subthemes
Taxonomy and definitions a. How the various types of RRs are defined?
b. What are the standard definitions for rapid reviews?
c. What are the purpose and use of the various types of RRs?
• Understand how they support informed health care decision-making
• Evaluate the scope and limitations of rapid reviews in health policy decision-making
Methods, process, and application a. What are the core elements for RR development (for example, timelines, number of reviewers,
number of databases searched)?
b. What are the steps to conduct RRs?
c. How are RR questions developed?
• Identify and develop products that work for various review questions and contexts
d. What trade-offs of time, resources, and comprehensiveness in various RR products impact results
and conclusions?
• Assess potential biases of RRs and the implications for reporting results
e. What are the appropriate search strategies, including different approaches to text mining, and
streamlined approaches?
f. What are the best practices for data synthesis, reporting, and interpretation?
g. What are the best practices for communicating results and knowledge mobilization?
h. Is it appropriate to use RRs for health care decision-making?
• Determine when and when not to use RR
i. What are the best practices for working with end users?
Compare and contrast rapid reviews with
systematic reviews
a. What are the similarities and differences in methods between RRs and SRs and their implications
for results?
• Investigate how to quantify bias in conclusions and recommendations
b. What are the qualitative versus quantitative methods for RRs with SR counterparts?
c. What are the strengths and limitations of RRs versus SRs?
• Address potential biases, accuracy, and precision of RRs vs SRs
• Consider perspectives of producers and users
• Identify shortcuts that can be used in RR products without compromising their quality
Evaluate use (including for quality assurance
and impact)
a. How are RRs and SRs used by various organizations?
• Identify who are the users of RRs and how they use them
• Measure and quantify their use and impact in health care decision-making
b. What are the risks decision makers are willing to accept in using RRs?
c. What is the impact on policy decisions and practice change?
d. Is it appropriate to use rapid reviews in cost-effectiveness analyses?
Database a. What are the opportunities and constraints for a RR international database or clearinghouse?
b.How can the identification of RRs be improved to reduce duplicate requests?
Influencing RR practice a. How can the application of RRs be enhanced among their users?
• Educate end users regarding what is feasible with RRs
• Determine what end-user need(s) RRs can meet
• Work with users in defining the question(s), conducting the reviews, interpreting results
RR tools and guideline development a. What tools and guidelines can be developed to improve the production and reporting of RRs?
• AMSTAR-like tool to guide the RR process
• Process map or decision tree to guide use of RRs and/or SRs
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and other key stakeholders, such as patients and the public,
was cited.
Discussion
The dialogue at the Summit highlighted the growing rele-
vance, practices, and gaps central to rapid reviews. The re-
search topics that emerged from the invited speakers and
discussions centered on three key areas including (1) how
to conduct a rapid review (i.e., deriving a taxonomy of rapid
reviews, understanding their methods, application and in-
fluence on practice, suggestions for tool and guideline de-
velopment); (2) how to understand validity and utility of
rapid reviews (i.e., theory and taxonomy, comparing and
contrasting with systematic reviews, evaluation of use); and
(3) how to better access rapid reviews (i.e., developing a
database or repository of rapid reviews). The authors ac-
knowledge that several of these topics currently are being
addressed or planned for in the near future.
Summit participants highlighted the priority of develop-
ing definitions and bringing more precision to terminology
that describe different accelerated synthesis products. They
considered this step to be essential to ongoing develop-
ment, comparative research, and evaluation of rapid review
use and impact. In addition, work is needed to clarify ap-
propriate methods for all stages of product development
[1–12], including the development of norms and practices
to address the lack of transparency in reporting. Resources
and tools are needed to support methodological decisions
by outlining essential steps given different timelines, poten-
tial complexities, and type of advice being sought.
Participants expressed an interest in the development
of methods for rapid reviews that benefit from and are
anchored in the science of systematic reviews. Arguably,
the systematic review approach has come a long way
over the last 22 years and continues to be refined [13];
thus, there are substantial methods with much that can
be learned from comparative studies. This area of
needed research includes evaluations on the impact of
streamlining systematic review methods, and compara-
tive research to strengthen the caliber of literature
searches. The purpose of the research is to explore quality
assurance as it relates to the reduced number of internal re-
viewers with rapid reviews, to determine methods to assess
and reduce the risk of bias, and to evaluate the relative im-
pacts of these various approaches.
Good scientific endeavor in rapid reviews is built
around transparency and accountability [14]. Yet rapid
reviews are frequently not published given the service
nature of these products. Consistent reporting, the abil-
ity to register with a central site, and publishing, either
formally through peer-reviewed journals or informally
using websites, social media, or other means, are needed
as the science advances. The development of a centrally
located repository or rapid review database was widely
supported with the provision that it be guided by stand-
ard definitions, shared terminology, and concepts and
categorized within the database. Questions related to the
type of infrastructure, proprietary considerations, data-
base management, and current terminology inconsisten-
cies were highlighted for further investigation and
discussion.
Numerous agencies are in the process of defining and
refining their approaches to rapid reviews, creating op-
portunities for sharing best practices and lessons
learned, and collaborating in the development of the
theory, taxonomy, and methodology to guide the devel-
opment and use of rapid reviews. The formation of the
Cochrane Rapid Review Methods group, which proposes
to provide training and support, track research, and
serve as a discussion forum for rapid reviews, and the
recently established Guidelines International Network
(G-I-N) working group that will work toward guideline
development, production, testing, and dissemination of
essential materials were among the many initiatives
highlighted. Forging a community of practice, composed
of knowledge producers and end users, is essential for
the sharing of emerging practices, lessons learned, and
priority areas for further research and development [15].
The Cochrane Methods Rapid Reviews and G-I-N are
promising initiatives for the growing field, given the con-
nectivity of these organizations to the wider evidence
synthesis community.
Conclusions
Rapid reviews have become ubiquitous in health care,
with local and global agencies emerging as expert hubs.
Producers and end users of rapid reviews that assembled
for the Summit shared focused considerations of the
current state of rapid reviews, noting tremendous het-
erogeneity in methods, approaches, and products. The
Table 1 A research agenda for rapid reviews (Continued)
• Guideline or checklist of what to include in RRs
• Checklists that assist with selection of RR products suitable for questions
• Flowchart of questions to support question development
• Quality assessment of RR products based on content and validity
• Reporting guidelines for RRs
AMSTAR Assessing the Methodological Quality of Systematic Reviews, RR rapid review, SR systematic review
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Summit formed a valuable platform for discussion of ef-
forts currently underway to advance the science and
strengthen methodologies, accountability, and transpar-
ency of rapid reviews. It also accessed the experiences
and perspectives of decision makers, who spoke of con-
textual realities, along with tensions between the evi-
dence base and the experience base of health care
professionals, reinforcing the importance of high-level
leadership that embraces the pursuit and advancement
of evidence-informed policy and practice.
The research agenda generated by Summit participants
aligns with the conclusions found in two 2015 studies
on rapid reviews and offers a reference point and poten-
tial road map for evidence synthesis producers and end
users. Yet, the importance of strategic leadership to
build and promote scientific momentum was seen as es-
sential. Constructively harnessing the talents of pro-
ducers and users of rapid reviews will be instrumental in
establishing and bringing scientific rigor to the field. The
speakers’ presentations from the Summit are also avail-
able on the CADTH website at https://www.cadth.ca/
cadth-summit-series.
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